TNF-α and IL-10 promoter polymorphisms, HPV infection, and cervical cancer risk

scientific article published on 17 May 2012

TNF-α and IL-10 promoter polymorphisms, HPV infection, and cervical cancer risk is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1037452497
P356DOI10.1007/S13277-012-0408-1
P698PubMed publication ID22592655

P50authorCarlos GolijowQ61978078
P2093author name stringAnahí Contreras
Gisela Barbisan
Luis Orlando Pérez
P2860cites workLymphoproliferative responses to human papillomavirus (HPV) type 16 proteins E6 and E7: outcome of HPV infection and associated neoplasiaQ73689490
The -238 tumor necrosis factor-alpha promoter polymorphism is associated with decreased susceptibility to cancersQ73734124
Different transcriptional activity and in vitro TNF-alpha production in psoriasis patients carrying the TNF-alpha 238A promoter polymorphismQ73873232
Tumor necrosis factor alpha promoter polymorphism at position -238 is associated with chronic active hepatitis C infectionQ74355873
TNFalpha polymorphism frequencies in HPV-associated cervical dysplasiaQ75431905
Genotyping for polymorphisms in interferon-gamma, interleukin-10, transforming growth factor-beta 1 and tumour necrosis factor-alpha genes: a technical reportQ77664161
Familial risks in cervical cancer: is there a hereditary component?Q78123197
Associations of promoter region polymorphisms in the tumour necrosis factor-alpha gene and early-onset psoriasis vulgaris in a northern Polish populationQ80439150
TNF-alpha promoter polymorphisms and susceptibility to human papillomavirus 16-associated cervical cancerQ81412462
Ethnic differences in allelic distribution of IFN-g in South African women but no link with cervical cancerQ24802483
The allelic distribution of -308 Tumor Necrosis Factor-alpha gene polymorphism in South African women with cervical cancer and control womenQ25257248
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008Q27860674
A simple salting out procedure for extracting DNA from human nucleated cellsQ27861086
Papillomaviruses and cancer: from basic studies to clinical applicationQ29614745
Epidemiologic classification of human papillomavirus types associated with cervical cancerQ29616213
Comparison between the Hybrid Capture II test and a PCR-based human papillomavirus detection method for diagnosis and posttreatment follow-up of cervical intraepithelial neoplasiaQ33885141
Inflammation promotes Barrett's metaplasia and cancer: a unique role for TNFalpha.Q34237117
Binding and biological effects of tumor necrosis factor alpha on cultured human neonatal foreskin keratinocytesQ34567983
Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activationQ36082965
Comparison of a one-step and a two-step polymerase chain reaction with degenerate general primers in a population-based study of human papillomavirus infection in young Swedish womenQ37119155
Association between TNF-α polymorphisms and cervical cancer risk: a meta-analysisQ37889149
Analysis of TNFα promoter SNPs and the risk of cervical cancer in urban populations of Posadas (Misiones, Argentina).Q40004016
Identification and characterization of a novel repressor site in the human tumor necrosis factor alpha geneQ40399069
Role of tumor necrosis factor-alpha in disease states and inflammation.Q40861731
The -308 tumor necrosis factor-alpha promoter polymorphism effects transcription.Q41117030
Interleukin-10 promoter polymorphisms and susceptibility to skin squamous cell carcinoma after renal transplantationQ42435925
Human leukocyte antigen (HLA) and single nucleotide polymorphisms (SNPs) tumor necrosis factor (TNF)-alpha -238 and -308 as genetic markers of susceptibility to psoriasis and severity of the disease in a long-term follow-up Brazilian studyQ42865668
IL-10 promoter nt -1082A/G polymorphism and human papillomavirus infection in cytologic abnormalities of the uterine cervixQ43782895
Cancer of the uterine cervix may be significantly associated with a gene polymorphism coding for increased IL-10 productionQ43824472
Interleukin-10 -1082 gene polymorphism and susceptibility to cervical cancer among Japanese womenQ43946365
Host genetic polymorphism analysis in cervical cancerQ44079693
Interleukin-10 and Fas polymorphisms and susceptibility for (pre)neoplastic cervical disease.Q44266468
TAP1, TAP2, and HLA-DR2 alleles are predictors of cervical cancer riskQ44822331
Allele frequencies of polymorphisms of the tumour necrosis factor-alpha, interleukin-10, interferon-gamma and interleukin-2 genes in a North European Caucasoid group from the UK.Q46836880
Interleukin-10 promoter polymorphisms in Southern Chinese patients with systemic lupus erythematosusQ47973471
Polymorphism at the -308-promoter position of the tumor necrosis factor-alpha (TNF-alpha) gene and cervical cancerQ48013794
An investigation of polymorphism in the interleukin-10 gene promoterQ48054541
Natural history of cervicovaginal papillomavirus infection in young women.Q50909200
Cytokine production patterns in cervical intraepithelial neoplasia: association with human papillomavirus infection.Q50976561
A combination of human leukocyte antigen DQB1*02 and the tumor necrosis factor alpha promoter G308A polymorphism predisposes to an insulin-deficient phenotype in patients with type 2 diabetes.Q51536130
Identifying the combination of genetic factors that determine susceptibility to cervical cancer.Q52000362
Interaction of immunological genes on chromosome 2q33 and IFNG in susceptibility to cervical cancerQ56899667
Prognostic Value of Intratumoral Interferon Gamma Messenger RNA Expression in Invasive Cervical CarcinomasQ56966580
Prognostic value of cytokine and soluble Fcγ receptor assays in oncologyQ56966881
Carcinogenicity of human papillomavirusesQ58296516
Allele frequencies of polymorphisms of TNFA, IL-6, IL-10 and IFNG in an Italian Caucasian populationQ60748340
Tumor necrosis factor in solid tumors: increased blood levels in the metastatic diseaseQ68001243
P433issue5
P921main subjectcervix uterine cancerQ160105
P304page(s)1549-1556
P577publication date2012-05-17
P1433published inTumor BiologyQ15757842
P1476titleTNF-α and IL-10 promoter polymorphisms, HPV infection, and cervical cancer risk
P478volume33

Reverse relations

cites work (P2860)
Q86390158A systemic assessment of the association between tumor necrosis factor alpha 308 G/A polymorphism and risk of cervical cancer
Q36095423Association between interluekin-17 gene polymorphisms and the risk of cervical cancer in a Chinese population
Q35479972Association between tumor necrosis factor alpha rs1800629 polymorphism and risk of cervical cancer
Q41654272Association of IL-10 GTC haplotype with serum level and HPV infection in the development of cervical carcinoma
Q35064064Association of common polymorphisms in TNFA, NFkB1 and NFKBIA with risk and prognosis of esophageal squamous cell carcinoma
Q37661158Cervical Carcinogenesis and Immune Response Gene Polymorphisms: A Review.
Q36677481Circulating interleukin-10 levels and human papilloma virus and Epstein-Barr virus-associated cancers: evidence from a Mendelian randomization meta-analysis based on 11,170 subjects
Q40216563Correlation of IL-27 genetic polymorphisms with the risk and survival of cervical cancer in a Chinese Han population
Q90465786Correlative analysis of the expression of IL-10 and Ki-67 in human cervical cancer and cervical intraepithelial neoplasias and human papillomavirus infection
Q40364658Genetic polymorphisms in MMP 2, 3, 7, and 9 genes and the susceptibility and clinical outcome of cervical cancer in a Chinese Han population
Q57193145Human Papilloma Virus Vaccine Awareness and Vaccination History in Patients Attending STI Clinics in Lagos and Ibadan, Nigeria
Q57149115LINC00673 rs11655237 Polymorphism Is Associated With Increased Risk of Cervical Cancer in a Chinese Population
Q39164454Metadherin confers chemoresistance of cervical cancer cells by inducing autophagy and activating ERK/NF-κB pathway
Q54213961MicroRNA-92a promotes tumor growth and suppresses immune function through activation of MAPK/ERK signaling pathway by inhibiting PTEN in mice bearing U14 cervical cancer.
Q38403881Positive association between lymphotoxin-alpha variation rs909253 and cancer risk: a meta-analysis based on 36 case-control studies
Q59789557Preliminary analysis of single-nucleotide polymorphisms in IL-10, IL-4, and IL-4Rα genes and profile of circulating cytokines in patients with gastric Cancer
Q38110235Quantitative analysis of the association between interleukin-10 1082A/G polymorphism and susceptibility to sepsis
Q39530290Relationship between gene polymorphisms of two cytokine genes (TNF-α and IL-6) and occurring of lung cancers in the ethnic group Han of China
Q36028161Risk allelic load in Th2 and Th3 cytokines genes as biomarker of susceptibility to HPV-16 positive cervical cancer: a case control study
Q38051275Significant association between CYP1A1 T3801C polymorphism and cervical neoplasia risk: a systematic review and meta-analysis
Q55085960Significant association between interleukin-10 gene polymorphisms and cervical cancer risk: a meta-analysis.
Q41539496TNF-α -308 G/A as a risk marker of cervical cancer progression in the Polish population
Q39446905The association between the poly(A) polymorphism in the VDR gene and cancer risk: a meta-analysis
Q41908794The association of the immune response genes to human papillomavirus-related cervical disease in a Brazilian population.
Q54982266The correlation between TNF-α-308 gene polymorphism and susceptibility to cervical cancer.
Q38211087The role of inflammation in cervical cancer
Q39631773Tumor Necrosis Factor Alpha (-238 / -308) and TNFRII-VNTR (-322) Polymorphisms as Genetic Biomarkers of Susceptibility to Develop Cervical Cancer Among Tunisians
Q34981240Tumor necrosis factor alpha rs1800629 polymorphism and risk of cervical lesions: a meta-analysis

Search more.